Carlos N. Velez is a Chief Executive Officer at Connexin Therapeutics Ltd. based in New York, New York, United States, North America. I am the founder and Managing Partner of Lacerta Bio, a global pharmaceutical business development consultancy that specializes in identifying, assessing, negotiating, and closing licensing and partnership opportunities. We work with pharmaceutical, biotechnology, and investor clients across various therapeutic and technology areas, providing them with market research, due diligence, transactional advisory, and other related services. We have successfully completed multiple engagements with companies from the US, Europe, Asia, and beyond, leveraging our extensive network and expertise. I also teach several Fundamentals in Pharmaceuticals and Biotech Licensing courses, where I share my insights and best practices with aspiring and experienced professionals in the field. I am also the co-founder and CEO of Connexin Therapeutics, I lead a team of scientists and entrepreneurs who are developing small molecules that protect and preserve vision in glaucoma and other ophthalmic conditions. We have achieved proof of concept in animal models and are raising our second round of financing to advance our pipeline and expand into new indications and new modalities.
Current Position: Chief Executive Officer
Company: Connexin Therapeutics Ltd.
Location: New York, New York, United States, North America
Social: Professional profiles available
Network: Extensive professional connections